Alkylating agents and biologic agents. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy7

Cell Line Tumor Cells, Cultured Cell Line, Tumor CHO Cells Bone Marrow Cells, Cultured HeLa Cells

Organisms6

Burkholderia mallei Viruses Cricetinae Escherichia coli Cricetulus Bacteria

Diseases38

Arthritis, Rheumatoid Psoriasis Arthritis, Psoriatic Rheumatic Diseases Neoplasms Inflammatory Bowel Diseases Opportunistic Infections Anthrax Neoplasms, Second Primary Crohn Disease Spondylitis, Ankylosing Sarcoma, Yoshida Glioma Brain Neoplasms Leukemia L1210 Leukemia, Radiation-Induced Leukemia L5178 Glioblastoma Autoimmune Diseases Disease Progression Waldenstrom Macroglobulinemia Bacterial Infections Leukemia P388 Myelodysplastic Syndromes Lung Neoplasms Neoplasms, Experimental Carcinoma 256, Walker Fibrosarcoma Chromosome Aberrations Leukemia Leukemia, Lymphocytic, Chronic, B-Cell Colorectal Neoplasms Multiple Myeloma Leukemia, Myeloid Leukopenia Fanconi Anemia Hodgkin Disease Breast Neoplasms

Chemicals and Drugs119

Alkylating Agents Biological Products Antineoplastic Agents, Alkylating Antirheumatic Agents O(6)-Methylguanine-DNA Methyltransferase Methylnitronitrosoguanidine Immunologic Factors Methyl Methanesulfonate Mechlorethamine Antibodies, Monoclonal Carmustine Chlorambucil Ethyl Methanesulfonate Nitrogen Mustard Compounds Dacarbazine Antibodies, Monoclonal, Humanized Antineoplastic Agents Melphalan Methotrexate Receptors, Tumor Necrosis Factor Dermatologic Agents Antibodies, Monoclonal, Murine-Derived Biological Factors Tumor Necrosis Factor-alpha Methylnitrosourea Guanine Cyclophosphamide Biological Warfare Agents Sulfuric Acid Esters Immunoconjugates Immunosuppressive Agents Mutagens Ethylnitrosourea Hazardous Substances Nitrosourea Compounds Methyltransferases Thiotepa Immunoglobulin G Triaziquone Phosphoramide Mustards Mustard Gas Mitomycins Aziridines Etanidazole Gastrointestinal Agents DNA Mitomycin DNA Glycosylases DNA Modification Methylases Anti-Inflammatory Agents Propiolactone Interleukin 1 Receptor Antagonist Protein Receptors, Interleukin-6 DNA Repair Enzymes Ethylmaleimide Nylons Lomustine DNA Adducts Nimustine Porfiromycin Methionine Sulfoximine Mesylates Cisplatin Quinacrine Mustard Dicumarol Anti-Inflammatory Agents, Non-Steroidal N-Glycosyl Hydrolases Glucocorticoids Buthionine Sulfoximine 4-Nitroquinoline-1-oxide Iodoacetamide Carcinogens Cyclohexenes Poly(ADP-ribose) Polymerases Cross-Linking Reagents DNA, Neoplasm Glutathione Poly Adenosine Diphosphate Ribose Sulfhydryl Compounds DNA-(Apurinic or Apyrimidinic Site) Lyase Busulfan Hydrazines Hydrocarbons, Brominated Netropsin Epoxy Compounds Doxorubicin Nitroimidazoles Recombinant Fusion Proteins Semustine Angiogenesis Inhibitors Novobiocin Reducing Agents Ifosfamide Mitolactol Vincristine Distamycins Topoisomerase Inhibitors Apurinic Acid Cytokines Cysteine Topoisomerase II Inhibitors Podophyllotoxin Glutathione Transferase Chemical Warfare Agents Aniline Mustard Epichlorohydrin Receptor, Epidermal Growth Factor Deoxyribonuclease IV (Phage T4-Induced)Carbon-Oxygen Lyases Vinca Alkaloids Antibiotics, Antineoplastic DNA-Binding Proteins Misonidazole Vidarabine Deoxycytidine Lucanthone Prednisone Recombinant Proteins RNA, Messenger

Analytical, Diagnostic and Therapeutic Techniques and Equipment29

Biological Therapy Bioprinting Drug Substitution Clinical Trials as Topic Treatment Outcome Drug Therapy, Combination Off-Label Use Antineoplastic Combined Chemotherapy Protocols Models, Biological Randomized Controlled Trials as Topic Molecular Targeted Therapy Combined Modality Therapy Drug Administration Schedule Remission Induction Drug Screening Assays, Antitumor Severity of Illness Index Retrospective Studies Prognosis Radiotherapy Registries Mutagenicity Tests Risk Factors Neoplasms, Experimental Biological Assay Chromatography, High Pressure Liquid Tumor Stem Cell Assay Transfection Risk Assessment Comet Assay

Phenomena and Processes28

Alkylation DNA Repair DNA Damage Drug Resistance Cell Survival Time Factors Dose-Response Relationship, Drug Mutation DNA Adducts Drug Synergism Drug Resistance, Neoplasm Kinetics Base Sequence Ultraviolet Rays Amino Acid Sequence Structure-Activity Relationship Base Pair Mismatch Apoptosis Biotransformation Chromosome Aberrations Molecular Structure Binding Sites Transfection Sister Chromatid Exchange Mutagenesis Protein Binding Gamma Rays Phenotype

Disciplines and Occupations2

Rheumatology Evidence-Based Medicine

Anthropology, Education, Sociology and Social Phenomena2

Biological Warfare Bioterrorism

Technology, Industry, Agriculture4

Bioprinting Biological Warfare Agents Nylons Chemical Warfare Agents

Information Science5

Molecular Sequence Data Base Sequence Amino Acid Sequence Databases, Factual Registries

Health Care16

Drug Substitution Security Measures Clinical Trials as Topic Treatment Outcome Managed Care Programs Randomized Controlled Trials as Topic Disaster Planning Severity of Illness Index Drug Costs Retrospective Studies Occupational Exposure Ultraviolet Rays Registries Risk Factors Risk Assessment Practice Guidelines as Topic

Geographicals1

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Technology, Industry, Agriculture Information Science Health Care Geographicals

Alkylating Agents Biological Therapy Biological Products Antineoplastic Agents, Alkylating Antirheumatic Agents Biological Warfare Arthritis, Rheumatoid Alkylation O(6)-Methylguanine-DNA Methyltransferase Bioterrorism Methylnitronitrosoguanidine Immunologic Factors Methyl Methanesulfonate Mechlorethamine Antibodies, Monoclonal Carmustine Chlorambucil Ethyl Methanesulfonate Psoriasis Nitrogen Mustard Compounds Dacarbazine Antibodies, Monoclonal, Humanized Bioprinting Antineoplastic Agents Melphalan DNA Repair Methotrexate Receptors, Tumor Necrosis Factor Drug Substitution Security Measures Dermatologic Agents Arthritis, Psoriatic Clinical Trials as Topic Rheumatic Diseases Antibodies, Monoclonal, Murine-Derived DNA Damage Treatment Outcome Biological Factors Tumor Necrosis Factor-alpha Burkholderia mallei Methylnitrosourea Guanine Cyclophosphamide Rheumatology Biological Warfare Agents Sulfuric Acid Esters Immunoconjugates Immunosuppressive Agents Mutagens Ethylnitrosourea Drug Therapy, Combination Off-Label Use Hazardous Substances Nitrosourea Compounds Methyltransferases Thiotepa Antineoplastic Combined Chemotherapy Protocols Immunoglobulin G Drug Resistance Triaziquone Phosphoramide Mustards Managed Care Programs Neoplasms Mustard Gas Mitomycins Cell Survival Aziridines Etanidazole Gastrointestinal Agents DNA Models, Biological Viruses Randomized Controlled Trials as Topic Inflammatory Bowel Diseases Mitomycin Time Factors DNA Glycosylases DNA Modification Methylases Anti-Inflammatory Agents Propiolactone Dose-Response Relationship, Drug Opportunistic Infections Interleukin 1 Receptor Antagonist Protein Receptors, Interleukin-6 DNA Repair Enzymes Molecular Targeted Therapy Ethylmaleimide Anthrax Disaster Planning Nylons Combined Modality Therapy Drug Administration Schedule Remission Induction Cricetinae Mutation Neoplasms, Second Primary Molecular Sequence Data Lomustine Cell Line DNA Adducts

No FAQ available that match "alkylating agents and biologic agents"